Dianomi Therapeutics
About:
Dianomi Therapeutics company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA).
Website: https://dianomitx.com/
Top Investors: Ligand Pharmaceuticals
Description:
Dianomi Therapeutics is a development stage biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of inflammatory diseases. With an initial focus on osteoarthritis and rheumatoid arthritis, They are working to enhance the safety, efficacy, and duration of effect of therapeutic agents by incorporating them with Thier proprietary mineral coated microparticle system (MCM).
$3.19M
$1M to $10M
Parker, Colorado, United States
2017-01-01
Anna Clements, Barry Kurokawa, Carter Cliff, Martin Ostrowski, William L. Murphy
11-50
2019-02-05
Private
© 2025 bioDAO.ai